|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| C12M 1/00 | |||
| C12M 1/34 | |||
| G01N 33/50 | |||
| C12N 15/09 | |||
| G01N 33/68 |
| (11) | Number of the document | 2505662 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10833015.0 |
| Date of filing the European patent application | 2010-10-26 | |
| (97) | Date of publication of the European application | 2012-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2010/068909 |
| Date | 2010-10-26 |
| (87) | Number | WO 2011/065168 |
| Date | 2011-06-03 |
| (30) | Number | Date | Country code |
| 2009266539 | 2009-11-24 | JP |
| (72) |
TSUZAKA, Kensei, JP
|
| (73) |
KayteeBio Co. & Ltd.,
VenturePlaza Funabashi No.110, 1-17-25, Kita-Honcho Funabashi-shi, Chiba 273-0864,
JP
|
| (54) | METHOD AND APPARATUS FOR PREDICTION OF PHARMACOLOGICAL EFFICACY OF HUMANIZED ANTI-TNF-alpha ANTIBODY DRUG ON RHEUMATOID ARTHRITIS |
| METHOD AND APPARATUS FOR PREDICTION OF PHARMACOLOGICAL EFFICACY OF HUMANIZED ANTI-TNF-alpha ANTIBODY DRUG ON RHEUMATOID ARTHRITIS |